Page last updated: 2024-09-03

blonanserin and Cognition Disorders

blonanserin has been researched along with Cognition Disorders in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, L; Liao, M; Liu, B; Xu, S; Zhang, Y; Zheng, Q1
Enomoto, T; Ikeda, K; Ikejiri, M; Iwamura, Y; Kiyoshi, A; Kotani, M; Matsumoto, A; Matsumoto, K; Murai, T; Nakako, T; Nakayama, T; Ogi, Y1
Ishibashi, T; Nakamura, H; Nishikawa, H; Une, T1
Anai, K; Arai, J; Funamoto, Y; Ito, Y; Kaneda, Y; Kitajima, R; Miyake, N; Miyamoto, S; Ogino, S; Ojima, K; Sumiyoshi, T; Tadokoro, M; Tenjin, T; Teramoto, H; Tsukahara, S; Yamaguchi, N1

Reviews

2 review(s) available for blonanserin and Cognition Disorders

ArticleYear
[Research progress in mechanisms and clinical application for blonanserin and lurasidone in improving cognitive function of schizophrenia].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2017, Apr-28, Volume: 42, Issue:4

    Topics: Antipsychotic Agents; Cognition Disorders; Humans; Lurasidone Hydrochloride; Piperazines; Piperidines; Schizophrenia; Schizophrenic Psychology

2017
[Pharmacological profiles and clinical effects of blonanserin (Lonasen) on schizophrenia].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2008, Volume: 132, Issue:6

    Topics: Animals; Antidepressive Agents, Second-Generation; Cognition Disorders; Dopamine D2 Receptor Antagonists; Double-Blind Method; Drug Discovery; Drug-Related Side Effects and Adverse Reactions; Humans; Piperazines; Piperidines; Randomized Controlled Trials as Topic; Schizophrenia; Serotonin 5-HT2 Receptor Antagonists; Treatment Outcome

2008

Trials

1 trial(s) available for blonanserin and Cognition Disorders

ArticleYear
Effect of blonanserin on cognitive function in antipsychotic-naïve first-episode schizophrenia.
    Human psychopharmacology, 2012, Volume: 27, Issue:1

    Topics: Adult; Analysis of Variance; Antipsychotic Agents; Chronic Disease; Cognition Disorders; Female; Humans; Male; Piperazines; Piperidines; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Young Adult

2012

Other Studies

1 other study(ies) available for blonanserin and Cognition Disorders

ArticleYear
The atypical antipsychotic blonanserin reverses (+)-PD-128907- and ketamine-induced deficit in executive function in common marmosets.
    Behavioural brain research, 2016, May-15, Volume: 305

    Topics: Animals; Antipsychotic Agents; Benzopyrans; Callithrix; Cognition Disorders; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Executive Function; Female; Ketamine; Male; Mental Recall; Oxazines; Piperazines; Piperidines

2016